Talphera (TLPH)

• Market cap: $74.2M
• 1 day: 0%
• 5 days: 13.49%
• 1 month: 20.17%
• 3 months: 62.81%
• 6 months: 71.75%
• Year to date: 23.28%
• 1 year: 265.26%
• 5 years: -94.04%
• 10 years: -98.01%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 12